Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: reply
Rheumatology (Oxford)
.
2020 Dec 1;59(12):e163-e164.
doi: 10.1093/rheumatology/keaa475.
Authors
Sarah Mackie
1
2
,
Lorna Neill
3
,
Dorothy Byrne
4
,
Susan Mollan
5
,
Bhaskar Dasgupta
6
,
Christian Dejaco
7
Affiliations
1
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds.
2
Leeds NIHR Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds.
3
PMR-GCA Scotland, Perth.
4
PMRGCAuk, London.
5
Birmingham Neuro-Ophthalmology Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham.
6
Rheumatology, Southend University NHS Foundation Trust, Westcliff-on-Sea, UK.
7
Rheumatology, Medical University Graz, Graz, Austria.
PMID:
33026077
DOI:
10.1093/rheumatology/keaa475
No abstract available
Publication types
Comment
MeSH terms
Ethnicity
Giant Cell Arteritis* / diagnosis
Giant Cell Arteritis* / drug therapy
Humans
Rheumatology*
Grants and funding
MR/N011775/1/MRC_/Medical Research Council/United Kingdom